ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 617

$632K Total Retail Price of All Prescriptions

Rank: 39 out of 617

375 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,357 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 522 455 1 2
FUROSEMIDE 462 381 2 4
LEVOTHYROXINE SODIUM 396 349 3 1
OMEPRAZOLE 391 319 4 3
POTASSIUM CHLORIDE 303 278 5 10
AMLODIPINE BESYLATE 292 269 6 6
METFORMIN HCL 281 207 7 9
METOPROLOL TARTRATE 246 223 8 11
LISINOPRIL 244 210 9 5
HYDROCODONE-ACETAMINOPHEN 238 171 S3 10 8
WARFARIN SODIUM 236 221 11 7
GABAPENTIN 234 196 12 16
ATENOLOL 204 179 13 17
METOPROLOL SUCCINATE 195 192 14 12
SERTRALINE HCL 192 136 15 20
RANITIDINE HCL 184 131 16 40
LOSARTAN POTASSIUM 183 166 17 22
ALENDRONATE SODIUM 167 159 18 25
TRAMADOL HCL 167 90 18 15
ATORVASTATIN CALCIUM 160 140 20 14
ALLOPURINOL 149 143 21 27
CITALOPRAM HBR 147 131 22 18
DONEPEZIL HCL 144 144 23 30
LANTUS 141 119 24 39
LYRICA 129 64 25 92
CARVEDILOL 124 104 26 19
FENTANYL 117 111 S2 27 45
DIGOXIN 116 105 28 48
AZITHROMYCIN 108 85 29 70
GLYBURIDE 103 82 R 30 84
ZOLPIDEM TARTRATE 103 82 30 23
POLYETHYLENE GLYCOL 3350 103 71 30 32
HYDROCHLOROTHIAZIDE 100 86 33 13
NAMENDA 100 100 33 35
OXYBUTYNIN CHLORIDE 89 89 35 88
DIOVAN 85 84 36 41
TAMSULOSIN HCL 84 84 37 26
CEFDINIR 82 65 38 169
SPIRONOLACTONE 79 49 39 42
LIPITOR 78 64 40 118
NABUMETONE 77 51 41 120
DETROL LA 76 66 42 127
ENALAPRIL MALEATE 69 53 43 34
CEFUROXIME 68 55 44 165
ROPINIROLE HCL 67 31 45 66
ADVAIR DISKUS 64 42 46 38
NEXIUM 63 51 47 43
PRAVASTATIN SODIUM 61 61 48 21
LEVOFLOXACIN 59 48 49 89
ACTOS 58 51 50 85
GLYBURIDE-METFORMIN HCL 57 56 R 51 157
DOXAZOSIN MESYLATE 57 52 51 79
TRIAMTERENE-HCTZ 55 35 53 47
NITROFURANTOIN MONO-MACRO 52 49 54 205
BUSPIRONE HCL 51 20 55 131
NOVOLOG 50 39 56 137
PREDNISONE 50 34 56 31
AGGRENOX 50 43 56 155
MELOXICAM 50 46 56 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.